Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioSphere Medical To Announce 1st Quarter, 2004 Earnings Results.


Business Editors

ROCKLAND, Mass.--(BUSINESS WIRE)--April 5, 2004

BIOSPHERE biosphere, irregularly shaped envelope of the earth's air, water, and land encompassing the heights and depths at which living things exist. The biosphere is a closed and self-regulating system (see ecology), sustained by grand-scale cycles of energy and of  MEDICAL, (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:BSMD), a medical device company that is pioneering the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply, announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, April 29th at 11:00 a.m. Eastern Time (10 a.m. Central Time).

The number to dial into the teleconference is (719) 867-0640. Please call in approximately ten minutes before the call is scheduled to begin. The call is being webcast by CCBN CCBN Central Coast Bancorp
CCBN Charles County Business Network
 and can be accessed at our web site: www.biospheremed.com. A replay of the teleconference will be available from 2:30 P.M. (ET) Thursday, April 29th until 12:00 A.M. (ET) on May 6, 2004. The replay dial-in number is: (719) 457-0820. The Access Code is 468899. A replay of the webcast will be available in the investor section of our company website at www.biospheremed.com.

The webcast is also being distributed over CCBN's Investor Distribution Network. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

About BioSphere Medical

BioSphere Medical, Inc., based in Rockland, Massachusetts Rockland is a town in Plymouth County, Massachusetts, United States. The population was 17,670 at the 2000 census. with 10,199 total registered voters as of December 31, 2005. , is a medical device company focused on embolotherapy, the treatment of uterine fibroids Uterine Fibroids Definition

Uterine fibroids (also called leiomyomas or myomas) are benign growths of the muscle inside the uterus. They are not cancerous, nor are they related to cancer.
, tumors and vascular malformations by occluding their blood supply. The Company is pioneering the use of patented and proprietary bioengineered microspheres as a new class of embolics. BioSphere Medical has received clearance in many countries, including the United States, Canada, Australia and the European Community, which allow the Company to sell its products for use in general embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun)
1. the process or condition of becoming an embolus.

2. therapeutic introduction of a substance into a vessel in order to occlude it.
 procedures, including uterine fibroid embolization Uterine Fibroid Embolization Definition

Uterine fibroids are growths in the muscular tissue of the womb (uterus). Uterine fibroid embolization is non-surgical removal of the growths through the use of a tubular device called a catheter.
.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 5, 2004
Words:310
Previous Article:Viper Networks Launches New ``IP Phone Adapter'' Product.
Next Article:Flightdocs Names Scott Sobel Vice President.



Related Articles
BioSphere Medical, Inc. Reports First-Quarter Financial Results and Growth Strategy Milestones.
BioSphere Medical Reports Fourth Quarter and Fiscal Year 2003 Financial Results.
BioSphere Medical To Announce 2nd Quarter, 2004 Earnings Results.
BioSphere Medical Reports Second Quarter 2004 Financial Results.
BioSphere Medical Appoints Richard J. Faleschini As CEO.
BioSphere Medical Reports Third Quarter 2004 Financial Results; Total Revenue Up 16%; Net Loss Decreased 21% from Prior Year Period.
BioSphere Medical Announces Court's Decision in Contract Claim Brought by Terumo Europe N.V.; BioSphere's French subsidiary required to pay...
BioSphere Medical Reports Fourth Quarter and Full Year 2004 Financial Results.
Dutton Associates Announces Investment Opinion: BioSphere Medical Strong Speculative Buy Rating in Initiating Coverage by Dutton Associates.
BioSphere Medical Reports Third Quarter 2005 Financial Results; Revenues Grow 27% in the Third Quarter of 2005 Compared to the Third Quarter of 2004.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles